Results 211 to 220 of about 584,870 (306)

Outcome of initial cord blood transplantation with FM80TBI as conditioning regimen for acute myeloid leukemia. [PDF]

Ann Hematol
Akimoto M, Tachibana T, Tanaka M, Izumi A, Takeda T, Fujimaki K, Tamai Y, Sato S, Fujita H, Suzuki T, Yamamoto K, Yamazaki E, Maeda N, Arai S, Hirose N, Nakajima H.   +15 more
europepmc   +1 more source

ITGB1 Regulates Triple‐Negative Breast Cancer Development by Modulating the Tumor Microenvironment

Advanced Science, EarlyView.
ABSTRACT Tumorigenesis and metastasis are frequently attributed to the intricate interplay between cancer cells and the tumor microenvironment (TME). Comprehending the mechanisms and key regulators of cancer‐immune crosstalk in the TME is imperative for developing efficacious immunotherapy.
Nuozi Song, Siqi Chen, Lei Wang, Jessica Dang, Xu Cao, Stephanie Singh, Lu Yang, Jinhui Wang, Steven T. Rosen, Yingyu Wang, Chun‐Wei D. Chen, Cheng Zhang, Mingye Feng   +12 more
wiley   +1 more source

Correction to: Overcoming transfusion-refractory anemia: partial splenic embolization to facilitate orthopedic surgery in β-thalassemia. [PDF]

Ann Hematol
Ye QQ, Zhou XG, Yang G, Xie WT, Yu AY, Duan HZ.   +5 more
europepmc   +1 more source

The impact of the graft-versus-leukemia effect on survival in acute lymphoblastic leukemia [PDF]

, 2019
et al,, Uy, Geoffrey, Yeshurun, Moshe
core   +1 more source

Loss of SOCS1 in Donor T Cells Exacerbates Intestinal GVHD by Driving a Chemokine‐Dependent Pro‐Inflammatory Immune Microenvironment

Advanced Science, EarlyView.
T cell‐specific Socs1 knockout leads to inflammatory differentiation of CD8+ T cells, prompting the STAT1/2 complex to drive the activation of Ccl5, Ccr5, and Cxcr3, and promoting the skewing of monocytes toward a pro‐inflammatory M1 macrophage lineage.
Zhigui Wu, Bixia Wang, Xinya Jiang, Fangqing Zhang, Qianqian Huang, Xinyi Wu, Shuang Fan, Qi Zhang, Jingrui Zhou, Jianing Tang, Xiao‐Dong Mo, Yu Wang, Ying‐Jun Chang, Huidong Guo, Xiao‐Jun Huang   +14 more
wiley   +1 more source

Emapalumab use in malignancy-associated hemophagocytic lymphohistiocytosis in the United States: the REAL-HLH study. [PDF]

Blood Adv
Zoref-Lorenz A, Allen CE, Behrens EM, Chandrakasan S, Chien M, Hermiston ML, Hinson AP, Intzes S, Isakoff MS, Leiding JW, Oladapo A, Panigrahi A, Patel SA, Pednekar P, Ray AK, Rothman JA, Saldaña BD, Walkovich KJ, Weinstein J, Yee JD, Jordan MB, Weinstein J, Hinson AP, Allen CE, Eckstein OS, Gulati N, Chandrakasan S, Haines H, Nakano TA, Patel SA, Behrens EM, Intzes S, Hays A, Saldaña BD, Jordan MB, Zoref-Lorenz A, Hanna R, Isakoff M, Ray AK, Rothman JA, Tandra A, Cooper R, Leiding JW, Chien M, Sarangi S, Gidvani-Diaz VK, Satwani P, Carter J, Henry M, Gloude N, Bhatt S, Bhatla D, Draper L, Panigrahi A, Hermiston ML, Modica R, Riskalla M, Baker A, Ward B.   +58 more
europepmc   +1 more source

DCAF13 Safeguards Hematopoietic Stem Cells via RRS1‐Regulated Ribosome Biogenesis

Advanced Science, EarlyView.
This study establishes DCAF13 as an essential regulator for hematopoietic stem cell (HSC) function. Its deletion in mice causes lethal pancytopenia and HSC depletion. Mechanistically, DCAF13 interacts with RRS1 and mediates its non‐degradative K27‐linked ubiquitination, thereby stabilizing RRS1 to maintain ribosome biogenesis and protein translation ...
Mengke Li, Yuxin Wu, Shuai Zhou, Peipei Tang, Jiaming Wei, Ling Liu, Zhenyi Wang, Deyang Shi, Shengnan Yuan, Qingyu Zhang, Shihui Wang, Qing Zhang, Huan Zhao, Rui Zhang, Yingying Wang, Shiwei Yang, Xiangli Chen, Xiaojing Shi, Guangzhi Liu, Yuwei Zhang, Jinming Li, Xu Dong Zhang, Rick F Thorne, Dongping Wei, Zumin Zhu, Song Chen   +25 more
wiley   +1 more source

Case 22: A 65-Year-Old-Woman With Neutropenia. [PDF]

J Korean Med Sci
Kang MG, Chung Y, Kim J, Min KI.
europepmc   +1 more source

NIR‐Activatable Domino Cascade Catalysis Nanozyme Reactor for Multi‐Mechanism Synergistic Immunotherapy in Bladder Cancer

Advanced Science, EarlyView.
This study presents an intravesical delivery strategy of ferroptosis‐ and immunity‐inducing nanozyme‐loaded thermoresponsive hydrogels (FMCC@PNH) for enhanced bladder cancer therapy. Abstract Current intravesical therapies for bladder cancer after resection are limited by poor tissue penetration, off‐target effects, and insufficient efficacy.
Yongnan Jiang, Qingling Zhang, Yuhan Zhang, Xinlu Yu, Bo Jia, Yulong Dong, Yalong Wu, Kelong Fan, Xinquan Gu, Lei Ji, Wei Jiang, Bin Liu   +11 more
wiley   +1 more source

Efficacy of chimeric antigen receptor T-cell therapy in testicular relapse of pediatric acute lymphoblastic leukemia: a multicenter retrospective study. [PDF]

Front Immunol
Wang N, Tang Y, Zhuang Y, Cai J, Hu S, Yang X, Fang Y, Wu X, Wang N, Wang L, Zhai X, Yang M, Tian X, Wang Y, Li H, Zhao L, Li CK, Chen X, Zhu X.   +18 more
europepmc   +1 more source